• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PBK/TOPK表达可预测口腔癌的预后。

PBK/TOPK Expression Predicts Prognosis in Oral Cancer.

作者信息

Chang Chin-Fang, Chen Sung-Lang, Sung Wen-Wei, Hsieh Ming-Ju, Hsu Hui-Ting, Chen Li-Hsin, Chen Mu-Kuan, Ko Jiunn-Liang, Chen Chih-Jung, Chou Ming-Chih

机构信息

Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.

Department of Otorhinolaryngology, Head and Neck Surgery, Jen-Ai Hospital, Taichung 400, Taiwan.

出版信息

Int J Mol Sci. 2016 Jun 24;17(7):1007. doi: 10.3390/ijms17071007.

DOI:10.3390/ijms17071007
PMID:27347940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4964383/
Abstract

Oral cancer is a common cancer with poor prognosis. We evaluated the expression of PBK/TOPK (PDZ-binding kinase/T-LAK cell-originated protein kinase) and its prognostic significance in oral cancer. PBK/TOPK expression was measured by immunohistochemical staining of samples from 287 patients with oral cancer. The association between PBK/TOPK expression and clinicopathological features was analyzed. The prognostic value of PBK/TOPK for overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. A high PBK/TOPK expression level was correlated with long overall survival. The prognostic role of PBK/TOPK expression was significant in young patients (p < 0.05), patients with smoking habits (p < 0.05), and late stage disease (p < 0.05). Our results suggest that PBK/TOPK expression is enhanced in oral cancer. High PBK/TOPK expression, either alone or in subgroups according to clinicopathological features, may serve as a favorable prognostic marker for patients with oral cancer.

摘要

口腔癌是一种预后较差的常见癌症。我们评估了PBK/TOPK(PDZ结合激酶/T-LAK细胞源蛋白激酶)的表达及其在口腔癌中的预后意义。通过对287例口腔癌患者的样本进行免疫组织化学染色来检测PBK/TOPK的表达。分析PBK/TOPK表达与临床病理特征之间的关联。通过Kaplan-Meier分析和Cox比例风险模型确定PBK/TOPK对总生存期的预后价值。PBK/TOPK高表达水平与较长的总生存期相关。PBK/TOPK表达的预后作用在年轻患者(p<0.05)、有吸烟习惯的患者(p<0.05)和晚期疾病患者(p<0.)中具有显著性。我们的结果表明口腔癌中PBK/TOPK表达增强。高PBK/TOPK表达,无论是单独还是根据临床病理特征分为亚组,都可能作为口腔癌患者的一个良好预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4873/4964383/8379295c8556/ijms-17-01007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4873/4964383/cc3acb446c2b/ijms-17-01007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4873/4964383/8379295c8556/ijms-17-01007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4873/4964383/cc3acb446c2b/ijms-17-01007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4873/4964383/8379295c8556/ijms-17-01007-g002.jpg

相似文献

1
PBK/TOPK Expression Predicts Prognosis in Oral Cancer.PBK/TOPK表达可预测口腔癌的预后。
Int J Mol Sci. 2016 Jun 24;17(7):1007. doi: 10.3390/ijms17071007.
2
Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.细胞质、核和总 PBK/TOPK 表达与结直肠癌患者的预后相关:基于组织微阵列免疫组化染色的回顾性分析。
PLoS One. 2018 Oct 4;13(10):e0204866. doi: 10.1371/journal.pone.0204866. eCollection 2018.
3
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.PBK/TOPK的过表达与胃癌的肿瘤恶性潜能及不良预后相关。
Br J Cancer. 2017 Jan 17;116(2):218-226. doi: 10.1038/bjc.2016.394. Epub 2016 Nov 29.
4
PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.PBK/TOPK的表达与突变型p53相关,并影响肺腺癌患者的预后以及细胞增殖和生存能力。
Hum Pathol. 2015 Feb;46(2):217-24. doi: 10.1016/j.humpath.2014.07.026. Epub 2014 Oct 30.
5
Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.PBK/TOPK的过表达促进食管鳞状细胞癌的肿瘤发展及不良预后。
Anticancer Res. 2016 Dec;36(12):6457-6466. doi: 10.21873/anticanres.11244.
6
PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.PBK/TOPK 在非小细胞肺癌中的表达:与 Ki67 和 p53 表达的相关性及其预后意义。
Histopathology. 2013 Nov;63(5):696-703. doi: 10.1111/his.12215. Epub 2013 Sep 11.
7
Expression of PBK/TOPK in cervical cancer and cervical intraepithelial neoplasia.PBK/TOPK在宫颈癌及宫颈上皮内瘤变中的表达。
Int J Clin Exp Pathol. 2014 Oct 15;7(11):8059-64. eCollection 2014.
8
Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.PDZ 结合激酶/T-LAK 细胞起源的蛋白激酶(PBK/TOPK)在人膀胱移行细胞癌中的表达。
Immunobiology. 2014 Jun;219(6):469-74. doi: 10.1016/j.imbio.2014.02.003. Epub 2014 Feb 25.
9
Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis.PBK/TOPK 的过表达与乳腺癌患者的预后不良相关:一项回顾性分析。
World J Surg Oncol. 2022 Sep 28;20(1):316. doi: 10.1186/s12957-022-02769-x.
10
Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer.PDZ结合激酶/T-LAK细胞源蛋白激酶(PBK/TOPK)在癌症患者中的预后价值
J Cancer. 2019 Jan 1;10(1):131-137. doi: 10.7150/jca.28216. eCollection 2019.

引用本文的文献

1
TOPK Drives IL19-Mediated Crosstalk Between Cancer Cells and Fibroblasts to Promote Solar UV-Induced Skin Damage and Carcinogenesis.TOPK驱动白细胞介素-19介导的癌细胞与成纤维细胞之间的串扰,以促进太阳紫外线诱导的皮肤损伤和致癌作用。
Cancers (Basel). 2025 Jun 20;17(13):2067. doi: 10.3390/cancers17132067.
2
Phosphorylation of PBK at Thr9 by CDK5 correlates with invasion of prolactinomas.CDK5 对 PBK 的 Thr9 位磷酸化与泌乳素瘤的侵袭相关。
CNS Neurosci Ther. 2024 Feb;30(2):e14629. doi: 10.1111/cns.14629.
3
KRAS mutation-induced TOPK overexpression contributes to tumour progression in non-small cell lung cancer.

本文引用的文献

1
Oral Cavity Cancer: Risk Factors, Pathology, and Management.口腔癌:危险因素、病理学与管理
Oncology. 2015;89(4):187-95. doi: 10.1159/000398801. Epub 2015 Jun 17.
2
Head and neck cancers in developing countries.发展中国家的头颈癌
Rambam Maimonides Med J. 2014 Apr 28;5(2):e0009. doi: 10.5041/RMMJ.10143. eCollection 2014 Apr.
3
Oxidative and antioxidative mechanisms in oral cancer and precancer: a review.口腔癌和癌前病变中的氧化和抗氧化机制:综述。
KRAS 基因突变诱导 TOPK 过表达促进非小细胞肺癌肿瘤进展。
J Cell Mol Med. 2023 Jun;27(12):1637-1652. doi: 10.1111/jcmm.17640. Epub 2023 May 24.
4
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.NCBP2 和 TFRC 是口腔鳞状细胞癌的新型预后生物标志物。
Cancer Gene Ther. 2023 May;30(5):752-765. doi: 10.1038/s41417-022-00578-8. Epub 2023 Jan 12.
5
Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis.PBK/TOPK 的过表达与乳腺癌患者的预后不良相关:一项回顾性分析。
World J Surg Oncol. 2022 Sep 28;20(1):316. doi: 10.1186/s12957-022-02769-x.
6
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers.PBK/TOPK是一种与结肠癌抗肿瘤免疫相关的良好预后生物标志物。
Biomedicines. 2022 Jan 27;10(2):299. doi: 10.3390/biomedicines10020299.
7
PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.PBK/TOPK 抑制剂抑制催乳素瘤的进展。
Front Endocrinol (Lausanne). 2022 Jan 21;12:706909. doi: 10.3389/fendo.2021.706909. eCollection 2021.
8
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.PDZ 结合激酶高表达与肝癌预后不良和免疫浸润相关。
World J Surg Oncol. 2022 Jan 22;20(1):22. doi: 10.1186/s12957-021-02479-w.
9
MicroRNA-206 has a bright application prospect in the diagnosis of cases with oral cancer.微小 RNA-206 在口腔癌病例的诊断中有广阔的应用前景。
J Cell Mol Med. 2021 Sep;25(17):8169-8173. doi: 10.1111/jcmm.16598. Epub 2021 Aug 21.
10
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.PBK/TOPK:一种具有多种治疗潜力的有效药物靶点。
Cancers (Basel). 2021 May 6;13(9):2232. doi: 10.3390/cancers13092232.
Oral Oncol. 2014 Jan;50(1):10-8. doi: 10.1016/j.oraloncology.2013.09.011. Epub 2013 Oct 11.
4
PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.PBK/TOPK 在非小细胞肺癌中的表达:与 Ki67 和 p53 表达的相关性及其预后意义。
Histopathology. 2013 Nov;63(5):696-703. doi: 10.1111/his.12215. Epub 2013 Sep 11.
5
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.通过组织微阵列技术进行系统抗体生成和验证,从而鉴定乳腺癌中的新型蛋白质预后标志物。
BMC Cancer. 2013 Apr 2;13:175. doi: 10.1186/1471-2407-13-175.
6
Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation.在配对的恶性外周神经鞘瘤/丛状神经纤维瘤样本中对 519 个激酶基因的表达谱进行分析具有鉴别能力,并发现有丝分裂调节剂 BUB1B、PBK 和 NEK2 随着肿瘤转化而过度表达。
Mod Pathol. 2013 Jul;26(7):930-43. doi: 10.1038/modpathol.2012.242. Epub 2013 Feb 1.
7
Progression of precancerous lesions to oral cancer: results based on the Taiwan National Health Insurance Database.癌前病变进展为口腔癌:基于台湾全民健康保险数据库的结果。
Oral Oncol. 2013 May;49(5):427-30. doi: 10.1016/j.oraloncology.2012.12.004. Epub 2012 Dec 27.
8
c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas.c-Myc 和 E2F1 驱动高级恶性淋巴瘤中 PBK/TOPK 的表达。
Leuk Res. 2013 Apr;37(4):447-54. doi: 10.1016/j.leukres.2012.11.010. Epub 2012 Dec 10.
9
Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma.白细胞介素 6 在口腔鳞状细胞癌预后中的性别差异。
PLoS One. 2012;7(11):e50104. doi: 10.1371/journal.pone.0050104. Epub 2012 Nov 21.
10
High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients.白细胞介素 10 高表达可能预示早期口腔鳞状细胞癌患者预后不良。
Clin Chim Acta. 2013 Jan 16;415:25-30. doi: 10.1016/j.cca.2012.09.009. Epub 2012 Sep 12.